New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.

Sztanek F, Tóth LI, Pető A, Hernyák M, Diószegi Á, Harangi M

Open source

DOI
10.3390/biomedicines12061320
Published
2024 Jun 13
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines12061320,
  title = {New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.},
  author = {Sztanek F and Tóth LI and Pető A and Hernyák M and Diószegi Á and Harangi M},
  year = {2024},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines12061320},
  url = {https://doi.org/10.3390/biomedicines12061320}
}

RIS

TY  - JOUR
TI  - New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.
AU  - Sztanek F
AU  - Tóth LI
AU  - Pető A
AU  - Hernyák M
AU  - Diószegi Á
AU  - Harangi M
PY  - 2024
JO  - Biomedicines
DO  - 10.3390/biomedicines12061320
UR  - https://doi.org/10.3390/biomedicines12061320
ER  - 

APA

F, S., LI, T., A, P., M, H., Á, D., & M, H. (2024). New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.. Biomedicines. https://doi.org/10.3390/biomedicines12061320

Source records